Physician profile
Rachel E Farmer
NPI 1699822569
$1,011.81
in general payments reported to CMS, 2019-2025
21 companies · $121 in 2025
The $121 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $94.16 · 2021: $149 · 2022: $116 · 2023: $172 · 2024: $153 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $137.08 | 2022-2024 | Shingrix, Arexvy, Bexsero |
| Ironshore Pharmaceuticals INC. | $126.82 | 2019-2020 | |
| Corium, LLC | $113.44 | 2022-2025 | Azstarys |
| Novo Nordisk INC | $97.39 | 2019-2024 | Wegovy, Saxenda, Rybelsus |
| Merck Sharp & Dohme LLC | $84.63 | 2019-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Shire North American Group INC | $72.95 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.34 | 2021-2023 | Trintellix |
| Phathom Pharmaceuticals, INC. | $52.99 | 2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.54 | 2021-2023 | Xifaxan |
| Amgen INC. | $38.13 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $28.30 | 2021-2022 | |
| Dexcom, INC. | $26.04 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.89 | 2022 | |
| Upsher-Smith Laboratories LLC | $18.87 | 2021 | |
| Genentech USA, INC. | $17.99 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.54 | 2025 | Gemtesa |
| Zealand Pharma US, INC. | $13.44 | 2021 | |
| Exact Sciences Corporation | $13.08 | 2024 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $12.03 | 2020 | |
| Nevro Corp. | $11.78 | 2021 | |
| Sobi, INC | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.